Drug recall · October 25, 2017
methylPREDNIsolone ACETATE recall
Why: Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
- Lots / codes
Lot: 04252017@1, exp 5/9/2018
- Quantity
- 945 vials
- Company
- RXQ Compounding LLC, Athens, OH
- Distribution
- TX, LA, PA, MA, FL, and OH
- Initiated
- September 25, 2017 · Voluntary: Firm initiated
- Classified
- October 18, 2017
- Reported
- October 25, 2017
- Ended
- December 6, 2017
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylprednisolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.